oral glp 1 drugs GLP-1 Therapy: Pills vs Injections? Novo Nordisk's oral GLP-1 drug

Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024

Not approved for diagnostic, therapeutic, or medical applications

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.

GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing

This includes integrating the latest clinical trial data and delving into potential signaling pathways and pharmacological mechanisms

While some ingredients show limited potential, the evidence remains nuanced and should be interpreted carefully